Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Vos

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Blood|September 18, 1997
A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young womenF R Rosendaal, D S Siscovick, S M Schwartz, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 11, 2002
The activated protein C (APC)-resistant phenotype of APC cleavage site mutants of recombinant factor V in a reconstituted plasma modelM van der Neut Kolfschoten, R J Dirven, G Tans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2014
Functional analysis of two haplotypes of the human endothelial protein C receptor geneP Medina, S Navarro, E Bonet, et al.
Thrombosis and Haemostasis|April 26, 2000
The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosisM C de Visser, J F Guasch, P W Kamphuisen, et al.
Thrombosis and Haemostasis|December 29, 2000
The HR2 haplotype of factor V is not associated with the risk of myocardial infarctionC J Doggen, M C de Visser, H L Vos, et al.
Cancer Letters|March 23, 1995
Is episialin/MUC1 involved in breast cancer progression?J Hilkens, H L Vos, J Wesseling, et al.
Thrombosis and Haemostasis|June 12, 1999
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactionsP W Kamphuisen, J C Eikenboom, H L Vos, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2008
Prothrombotic gene variation and new vascular events after cerebral ischemia of arterial originD M O Pruissen, F R Rosendaal, C J M Frijns, et al.
British Journal of Haematology|November 28, 2001
High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII geneP W Kamphuisen, J C Eikenboom, F R Rosendaal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995
Metaxin, a gene contiguous to both thrombospondin 3 and glucocerebrosidase, is required for embryonic development in the mouse: implications for Gaucher diseaseP Bornstein, C E McKinney, M E LaMarca, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Blood|September 18, 1997
A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young womenF R Rosendaal, D S Siscovick, S M Schwartz, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 11, 2002
The activated protein C (APC)-resistant phenotype of APC cleavage site mutants of recombinant factor V in a reconstituted plasma modelM van der Neut Kolfschoten, R J Dirven, G Tans, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2014
Functional analysis of two haplotypes of the human endothelial protein C receptor geneP Medina, S Navarro, E Bonet, et al.
Thrombosis and Haemostasis|April 26, 2000
The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosisM C de Visser, J F Guasch, P W Kamphuisen, et al.
Thrombosis and Haemostasis|December 29, 2000
The HR2 haplotype of factor V is not associated with the risk of myocardial infarctionC J Doggen, M C de Visser, H L Vos, et al.
Cancer Letters|March 23, 1995
Is episialin/MUC1 involved in breast cancer progression?J Hilkens, H L Vos, J Wesseling, et al.
Thrombosis and Haemostasis|June 12, 1999
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactionsP W Kamphuisen, J C Eikenboom, H L Vos, et al.
Journal of Thrombosis and Haemostasis : JTH|July 30, 2008
Prothrombotic gene variation and new vascular events after cerebral ischemia of arterial originD M O Pruissen, F R Rosendaal, C J M Frijns, et al.
British Journal of Haematology|November 28, 2001
High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII geneP W Kamphuisen, J C Eikenboom, F R Rosendaal, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 1995
Metaxin, a gene contiguous to both thrombospondin 3 and glucocerebrosidase, is required for embryonic development in the mouse: implications for Gaucher diseaseP Bornstein, C E McKinney, M E LaMarca, et al.
Pageof 6